LCM
GILD icon

Lomas Capital Management’s Gilead Sciences GILD Stock Holding History

Lomas Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-55,000
Closed -$6.44M – 46
2015
Q2 		$6.44M Sell
55,000
-62,700
-53% -$6.85M 1.08% 32
2015
Q1 		$11.6M Buy
117,700
+24,560
+26% +$2.49M 2.03% 22
2014
Q4 		$8.78M Sell
93,140
-144,800
-61% -$15M 1.54% 28
2014
Q3 		$25.3M Sell
237,940
-8,550
-3% -$837K 4.91% 3
2014
Q2 		$20.4M Buy
+246,490
New +$19.2M 3.66% 9

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lomas Capital Management's GILD Position: Q3 2015 in Review

Lomas Capital Management sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 55,000 shares — an estimated $6.44M sold.

Lomas Capital Management first reported a position in GILD in Q2 2014 and held it in 5 quarters. The position peaked at $25.3M in Q3 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Lomas Capital Management reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • Lomas Capital Management sold 55,000 Gilead Sciences shares in Q3 2015, an estimated $6.44M.
  • Lomas Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 5 quarters.
  • Lomas Capital Management's Gilead Sciences position peaked at $25.3M in Q3 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Lomas Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.